NEW Product Technology


Siemens Consolidates Oncology Testing on a Single Platform

Siemans manSiemens Healthcare Diagnostics, Tarrytown, NY, introduces the LOCI® CA 19-9™ assay for use on Dimension Vista® Systems.

The release of this assay further expands the oncology menu for the Dimension Vista 1500 and Vista 500 systems, providing a core oncology menu to laboratories.

LOCI technology comprises a homogeneous, sandwich chemiluminescent immunoassay technology.

The oncology assays provide outstanding performance while consolidating even more tumor marker testing on a single platform. Features include:

  • Excellent precision for consistency in results reporting and accurate patient monitoring
  • Broad dynamic assay ranges to limit need for sample dilutions

  • Rapid assay kinetics to reduce TAT and provide better service levels to physicians and cancer patients anxiously awaiting results.
  • Minimal sample volumes to eliminate sample splitting and simplify workflow.

Click here to learn more.

[Source: Siemens Healthcare Diagnostics]